BIT
FURX

BlackRock Institutional Trust’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock Institutional Trust’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-243,580
Closed -$25.9M – 4037
2014
Q2 		$25.9M Sell
243,580
-126,140
-34% -$12.4M ﹤0.01% 1775
2014
Q1 		$32.2M Buy
369,720
+106,553
+40% +$8.23M 0.01% 1629
2013
Q4 		$11.1M Sell
263,167
-1,097
-0.4% -$45.1K ﹤0.01% 2357
2013
Q3 		$11.6M Buy
264,264
+1,860
+0.7% +$77K ﹤0.01% 2254
2013
Q2 		$8.94M Buy
+262,404
New +$9.21M ﹤0.01% 2380

BlackRock Institutional Trust's FURX Position: Q3 2014 in Review

BlackRock Institutional Trust sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 243,580 shares — an estimated $25.9M sold.

BlackRock Institutional Trust first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $32.2M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock Institutional Trust reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 243,580 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $25.9M.
  • BlackRock Institutional Trust first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • BlackRock Institutional Trust's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $32.2M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Institutional Trust's 13F filing for Q3 2014, filed 29 Oct 2014.